Alcon has announced that it will acquire STAAR Surgical Company, manufacturer of the Implantable Collamer Lens (ICL).
A Phase IIb clinical trial is set to begin for EXN407 – a novel eye-drop therapy for non-proliferative diabetic retinopathy and diabetic macular oedema
The immediate and predictable durability of Genentech’s Susvimo’s for the treatment of patients with neovascular age-related macular degeneration (nAMD) was sustained over five years,
A major randomised clinical trial has found that adjunctive topical corticosteroids and corneal cross-linking do not improve outcomes in bacterial keratitis beyond topical antibiotics
DISCLAIMER : THIS WEBSITE IS INTENDED FOR USE BY HEALTHCARE PROFESSIONALS ONLY.
By agreeing & continuing, you are declaring that you are a registered Healthcare professional with an appropriate registration. In order to view some areas of this website you will need to register and login.
If you are not a Healthcare professional do not continue.
